Nuclivision

0 reviews

Nuclivision is a Ghent-based medtech startup founded in 2022, specializing in AI-driven solutions to enhance nuclear medicine practices. Their flagship product, Nuclarity, is an advanced software platform designed to improve the efficiency and safety of PET (Positron Emission Tomography) imaging. By leveraging state-of-the-art AI algorithms, Nuclarity enables significant reductions in both scan times and the required doses of radioactive tracers, all while maintaining high diagnostic accuracy. This innovation addresses critical challenges in nuclear medicine, such as patient safety concerns, operational inefficiencies, and the growing demand for timely diagnostic procedures. Key Features and Functionality: - AI-Powered Image Enhancement: Nuclarity utilizes advanced deep learning techniques to enhance PET scan images, ensuring high-quality diagnostics even with reduced scan times and lower radiotracer doses. - Dose and Time Reduction: The software allows for up to a 50% reduction in both the administered radioactive dose and the duration of PET scans, minimizing radiation exposure and improving patient safety. - Seamless Integration: Nuclarity integrates smoothly with existing clinical workflows through the Nuclivision Gateway, facilitating easy adoption without disrupting current operations. - Scalability: Designed to meet the increasing demand for PET imaging, Nuclarity enhances scanner efficiency, enabling faster scheduling and better utilization of imaging resources. Primary Value and User Solutions: Nuclarity addresses several pressing issues in nuclear medicine: - Enhanced Patient Safety: By reducing radiation exposure, the software mitigates associated health risks, making PET scans safer for patients, particularly in pediatric cases and for those requiring repeated imaging. - Operational Efficiency: Shorter scan times and lower radiotracer usage lead to increased patient throughput and reduced operational costs, allowing imaging centers to handle higher volumes without compromising quality. - Improved Accessibility: The efficiency gains and safety improvements make PET imaging more accessible, addressing the growing demand for timely diagnostics in oncology and neurology. In summary, Nuclivision's Nuclarity revolutionizes PET imaging by combining AI-driven image enhancement with operational efficiencies, resulting in faster, safer, and more accessible nuclear medicine diagnostics.